20
Participants
Start Date
July 7, 2020
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
cytotoxic t-lymphocytes
EBV specific CTLs will be generated from HLA related matched and mismatched donors in a GMP facility and administered to the patient with refractory CTLs.
RECRUITING
New York Medical College, Valhalla
RECRUITING
Children's Hospital of Pennsylvania, Philadelphia
RECRUITING
Johns Hopkins, Baltimore
RECRUITING
Nationwide Children's Hosptial, Columbus
RECRUITING
Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee
RECRUITING
Washington University, St Louis
RECRUITING
Children's Hosptial Los Angeles, Los Angeles
RECRUITING
University of California San Francisco, San Francisco
Lead Sponsor
Children's Hospital of Philadelphia
OTHER
Medical College of Wisconsin
OTHER
Nationwide Children's Hospital
OTHER
Indiana University
OTHER
Washington University School of Medicine
OTHER
University of California, Los Angeles
OTHER
University of California, San Francisco
OTHER
New York Medical College
OTHER